日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF(V600)-mutant advanced melanoma patients: a propensity-matched survival analysis

更正:BRAF/MEK抑制剂一线治疗与抗PD-1单药治疗BRAF(V600)突变型晚期黑色素瘤患者的倾向性匹配生存分析

van Breeschoten, Jesper; Wouters, Michel W J M; Hilarius, Doranne L; Haanen, John B; Blank, Christian U; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; de Groot, Jan-Willem B; Hospers, Geke A P; Kapiteijn, Ellen; Piersma, Djura; van Rijn, Roos S; Suijkerbuijk, Karijn P M; Blokx, Willeke A M; Tije, Bert-Jan J Ten; Veldt, Astrid A M van der; Vreugdenhil, Art; Boers-Sonderen, Marye J; van den Eertwegh, Alfonsus J M

Discontinuation of anti-PD-1 monotherapy in advanced melanoma-Outcomes of daily clinical practice

晚期黑色素瘤患者停止抗PD-1单药治疗——日常临床实践结果

van Zeijl, Michiel C T; van den Eertwegh, Alfons J M; Wouters, Michel W J M; de Wreede, Liesbeth C; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; de Groot, Jan-Willem B; Hospers, Geke A P; Kapiteijn, Ellen; Piersma, Djura; van Rijn, Rozemarijn S; Suijkerbuijk, Karijn P M; Ten Tije, Albert J; van der Veldt, Astrid A M; Vreugdenhil, Gerard; van der Hoeven, Jacobus J M; Haanen, John B A G

First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF(V600)-mutant advanced melanoma patients: a propensity-matched survival analysis

BRAF/MEK抑制剂一线治疗与抗PD-1单药治疗BRAF(V600)突变型晚期黑色素瘤患者的疗效比较:一项倾向性匹配生存分析

van Breeschoten, Jesper; Wouters, Michel W J M; Hilarius, Doranne L; Haanen, John B; Blank, Christian U; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; de Groot, Jan-Willem B; Hospers, Geke A P; Kapiteijn, Ellen; Piersma, Djura; van Rijn, Roos S; Suijkerbuijk, Karijn P M; Blokx, Willeke A M; Tije, Bert-Jan J Ten; Veldt, Astrid A M van der; Vreugdenhil, Art; Boers-Sonderen, Marye J; van den Eertwegh, Alfonsus J M

Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients

检查点抑制剂诱发的肝炎及其与晚期黑色素瘤患者肝转移和预后的关系

Biewenga, Maaike; van der Kooij, Monique K; Wouters, Michel W J M; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; de Groot, Jan Willem B; Boers-Sonderen, Marye J; Hospers, Geke A P; Piersma, Djura; van Rijn, Rozemarijn S; Suijkerbuijk, Karijn P M; Ten Tije, Albert J; van der Veldt, Astrid A M; Vreugdenhil, Gerard; Haanen, John B A G; van der Eertwegh, Alfons J M; van Hoek, Bart; Kapiteijn, Ellen

Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer

评估 Khorana 评分、PROTECHT 评分和 5-SNP 评分在预测癌症患者静脉血栓栓塞方面的能力

Guman, Noori A M; van Geffen, Roos J; Mulder, Frits I; van Haaps, Thijs F; Hovsepjan, Vahram; Labots, Mariette; Cirkel, Geert A; Y F L de Vos, Filip; Ten Tije, Albert J; Beerepoot, Laurens V; Tjan-Heijnen, Vivianne C G; van Laarhoven, Hanneke W M; Hamberg, Paul; Vulink, Annelie J E; Los, Maartje; Zwinderman, Aeilko H; Ferwerda, Bart; Lolkema, Martijn P J K; Steeghs, Neeltje; Büller, Harry R; Kamphuisen, Pieter W; van Es, Nick

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial

在晚期黑色素瘤患者达到完全缓解或部分缓解后尽早停止PD-1阻断治疗:多中心前瞻性Safe Stop试验

Mulder, E E A P; de Joode, K; Litière, S; Ten Tije, A J; Suijkerbuijk, K P M; Boers-Sonderen, M J; Hospers, G A P; de Groot, J W B; van den Eertwegh, A J M; Aarts, M J B; Piersma, D; van Rijn, R S; Kapiteijn, E; Vreugdenhil, G; van den Berkmortel, F W P J; Hoop, E Oomen-de; Franken, M G; Ryll, B; Rutkowski, P; Sleijfer, S; Haanen, J B A G; van der Veldt, A A M

Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?

HER2阳性转移性乳腺癌患者长期使用曲妥珠单抗期间的心脏毒性:哪些患者需要进行心脏监测?

Bouwer, N I; Steenbruggen, T G; van Rosmalen, J; Rier, H N; Kitzen, J J E M; van Bekkum, M L; Tije, A J Ten; de Jong, P C; Drooger, J C; Holterhues, C; Smorenburg, C H; Kofflard, M J M; Boersma, E; Sonke, G S; Levin, M-D; Jager, A

Evaluation of the SAMEO-ATO surgical classification in a Dutch cohort

在荷兰人群中评估SAMEO-ATO手术分类

Ten Tije, Fleur A; Alkema, Sietze; van der Putten, Lisa; Koopman, Jan Pieter; Buwalda, Joeri; Kramer, Sophia E; Pauw, Robert Jan; Merkus, Paul

Practical applicability of the STAMCO and ChOLE classification in cholesteatoma care

STAMCO 和 ChOLE 分类在胆脂瘤治疗中的实际应用

Ten Tije, Fleur A; Merkus, Paul; Buwalda, Joeri; Blom, Henk M; Kramer, Sophia E; Pauw, Robert Jan

Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases

上市后试验与患者登记研究:晚期黑色素瘤脑转移患者的可比性

Ismail, Rawa K; Sikkes, Nienke O; Wouters, Michel W J M; Hilarius, Doranne L; Pasmooij, Anna M G; van den Eertwegh, Alfonsus J M; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; Boers-Sonderen, Marye J; de Groot, Jan Willem B; Haanen, John B A G; Hospers, Geke A P; Kapiteijn, Ellen; Piersma, Djura; van Rijn, Roos S; Suijkerbuijk, Karijn P M; Ten Tije, Bert-Jan; van der Veldt, Astrid A M; Vreugdenhil, Art; van Dartel, Maaike; de Boer, Anthonius